How Mission Becomes a Path to Margin at a Multispecialty Group, With Dan Greenleaf of Duly
Episode Description
Hospitals have increased their prices 256% over the last 20 years while physician compensation adjusted for inflation is down 36%. The average American family of four now spends $24,000 a year on healthcare — up from $6,000 in 2000 — while wages have risen far more slowly. Dan Greenleaf's argument is that in this environment, focusing on mission is not a financial sacrifice. It is a competitive advantage.
In this episode, Stacey Richter speaks with Dan Greenleaf, CEO of Duly Health and Care, a large multispecialty group in Chicago, about how Duly defines and measures mission across four concrete quadrants — affordability, access, consumer experience, and quality — and why achieving those quadrants reduces friction for patients and clinicians in ways that also produce financial sustainability. The margin show is EP489 Part 2.
WHAT YOU'LL LEARN
✅ Why affordability is the foundational mission quadrant: Duly's MRI costs $500 versus $4,500 at a Chicago hospital system, colonoscopies are $10,000 less, and the group estimates it saves employers, unions, and taxpayers in excess of $1 billion — likely closer to $2 billion — in the Chicago market alone
✅ How co-insurance math makes affordability a direct patient health issue: a $4,500 MRI at 20% co-insurance is $900 out of pocket versus $100 at Duly — and that $800 difference is the difference between patients seeking or delaying necessary care
✅ Why access at two days average wait time versus eight to sixty days at Chicago hospital systems is both a mission priority and a cost issue: an Avalere study found Duly Medicare fee-for-service patients had 15% fewer hospital admissions and 13% fewer ER admissions than comparable populations
✅ How Duly measures consumer experience with 50,000 Press Ganey survey responses per quarter and a net promoter score of 74 — above the 70 threshold for world-class, and compared to a 46 national hospital average — with price transparency explicitly built into the consumer experience definition
✅ Why Duly's prostate biopsy positive rate of 77% versus a national average of 25% is a proxy for diagnostic discipline — every unnecessary biopsy is both a quality failure and a financial harm to the patient
✅ How outbound activation campaigns for lung screening, colonoscopies, mammograms, and diabetic screening — work Duly does without getting paid for it — have detected hundreds of early-stage lung cancers and led to outcomes like a 25-day diagnosis-to-therapy timeline that Dan Greenleaf says nobody else achieves
WHY THIS MATTERS
Dan Greenleaf's framing is direct: there are only three ultimate payers in healthcare — taxpayers, employers and unions, and patients themselves — and everyone else is a middleman. The communities where Duly serves 40 to 50% of patients rank among the healthiest in the country. That is not incidental. When a clinical organization actually defines what mission means, measures it the way it measures any strategic priority, and builds operations around reducing friction for patients and clinicians, the mission and the margin move in the same direction.
=== LINKS ===
🔗 Show Notes with all mentioned links:
https://cc-lnk.com/EP489-Part1
✉️ Enjoy this podcast? Subscribe to the free weekly newsletter:
https://relentlesshealthvalue.com/join-the-relentless-tribe
🫙 Support the podcast with a small donation to the Tip Jar:
https://relentlesshealthvalue.com/join-the-relentless-tribe
🎤 Listen on Apple Podcasts https://podcasts.apple.com/us/podcast/feed/id892082003?ls=1
🎤 Listen on Spotify https://open.spotify.com/show/6UjgzI7bScDrWvZEk2f46b
📺 Subscribe to our YouTube channel https://www.youtube.com/@RelentlessHealthValue
=== CONNECT WITH THE RHV TEAM ===
✭ LinkedIn https://www.linkedin.com/company/relentless-health-value/
✭ Threads https://www.threads.net/@relentlesshealthvalue/
✭ Bluesky https://bsky.app/profile/relentleshealth.bsky.social
✭ X https://twitter.com/relentleshealth/
08:32 What should mission be in multispecialty?
08:54 Are mission and margin mutually exclusive?
10:47 What are the four "vectors" of Dan's mission?
11:32 Why does affordability matter?
12:11 EP466 with Vivian Ho, PhD.
12:40 EP488 with Mark Cuban and Cora Opsahl.
13:32 Who are the three payers in the marketplace?
17:31 EP388 with Merrill Goozner.
19:19 How does access play into mission?
20:28 EP464 with Al Lewis.
21:07 EP467 with Stacey.
22:56 Why price transparency is important to consumer experience.
24:16 LinkedIn post from Patrick Moore.
29:06 EP481 with Benjamin Schwartz, MD, MBA.
